Hyperfractionated, accelerated radiotherapy for locally advanced head and neck cancer: Quality of life in a prospective phase I/II trial

Radiotherapy and Oncology

Volumn 87, Issue 2, 2008, Pages 181-187

  Ringash, Jolie ^a,b   Lockwood, Gina ^b   O'Sullivan, Brian ^a,b   Warde, Padraig ^a,b   Bayley, Andrew ^a,b   Cummings, Bernard ^a,b   Kim, John ^a,b   Sellmann, Susanna ^b   Waldron, John ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b PRINCESS MARGARET HOSPITAL   (Canada)

Author keywords

Clinical trial; Fractionation; Head and neck neoplasms; Outcomes; Quality of life; Radiotherapy

Indexed keywords

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER RADIOTHERAPY; CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEAD AND NECK CANCER; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUALITY OF LIFE; RADIATION DOSE FRACTIONATION;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; DOSE FRACTIONATION; ENTERAL NUTRITION; FEMALE; HUMANS; LARYNGEAL NEOPLASMS; MALE; MIDDLE AGED; PHARYNGEAL NEOPLASMS; PROSPECTIVE STUDIES; QUALITY OF LIFE; RADIOTHERAPY DOSAGE; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 43049181327     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2007.12.028     Document Type: Article

References (22)

1. Ringash J., Warde P., Lockwood G., et al. Postradiotherapy quality of life for head-and-neck cancer patients is independent of xerostomia. Int J Radiat Oncol Biol Phys 61 (2005) 1403-1407
2. Elliott E.A., Wright J.R., Swann R.S., et al. Phase III Trial of an emulsion containing trolamine for the prevention of radiation dermatitis in patients with advanced squamous cell carcinoma of the head and neck: results of Radiation Therapy Oncology Group Trial 99-13. J Clin Oncol 24 (2006) 2092-2097
3. Cohen E.E.W., Haraf D.J., List M.A., et al. High survival and organ function rates after primary chemoradiotherapy for intermediate-stage squamous cell carcinoma of the head and neck treated in a multicenter phase II trial. J Clin Oncol 24 (2006) 3438-3444
4. Bourhis J., Overgaard J., Audry H., et al. Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis. Clin Otolaryngol 32 (2007) 119
5. Skladowski K., Maciejewski B., Golen M., et al. Randomized clinical trial on 7-day-continuous accelerated irradiation (CAIR) of head and neck cancer - report on 3-year tumour control and normal tissue toxicity. Radiother Oncol 55 (2000) 101-110
6. Dische S., Saunders M., Barrett A., et al. A randomised multicentre trial of CHART versus conventional radiotherapy in head and neck cancer. Radiother Oncol 44 (1997) 123-136
7. Jackson S.M., Weir L.M., Hay J.H., et al. A randomised trial of accelerated versus conventional radiotherapy in head and neck cancer. Radiother Oncol 43 (1997) 39-46
8. Cummings B., Keane T., Pintilie M., et al. Five year results of a randomized trial comparing hyperfractionated to conventional radiotherapy over four weeks in locally advanced head and neck cancer. Radiother Oncol 85 (2007) 7-16
9. Sobin L.H., and Wittekind C.H. International union against cancer TNM classification of malignant tumours vol. 1 (1997), John Wiley & Sons, New York p. 33-7
10. Ringash J., and Bezjak A. A structured review of quality of life instruments for head and neck cancer patients. Head Neck 23 (2001) 201-213
11. List M.A., D'Antonio L.L., Cella D.F., et al. The Performance Status Scale for Head and Neck Cancer Patients and the Functional Assessment of Cancer Therapy -Head and Neck Scale: a study of utility and validity. Cancer 77 (1996) 2294-2301
12. Cella D.F., Tulsky D.S., Gray G., et al. The Functional Assessment of Cancer Therapy scale: development and validation of the general measure. J Clin Oncol 11 (1993) 570-579
13. Ringash J., Bezjak A., O'Sullivan B., et al. Interpreting differences in quality of life: the FACT-H&N in laryngeal cancer patients. Qual Life Res 13 (2004) 725-733
14. Forastiere A.A., and Burtness B.A. Epidermal growth factor receptor inhibition in head and neck cancer - more insights, but more questions. J Clin Oncol 25 (2007) 2152-2155
15. Curran D., Giralt J., Harari P.M., et al. Quality of life in head and neck cancer patients after treatment with high-dose radiotherapy alone or in combination with cetuximab. J Clin Oncol 25 (2007) 2191-2197
16. Griffiths G.O., Parmar M.K., and Bailey A.J. Physical and psychological symptoms of quality of life in the CHART randomized trial in head and neck cancer: short-term and long-term patient reported symptoms. CHART Steering Committee. Continuous hyperfractionated accelerated radiotherapy. Br J Cancer 81 (1999) 1196-1205
17. Fisher J., Scott C., Scarantino C.W., et al. Phase III quality-of-life study results: impact on patients' quality of life to reducing xerostomia after radiotherapy for head-and-neck cancer - RTOG 97-09. Int J Radiat Oncol Biol Phys 56 (2003) 832-836
18. Duncan G.G., Epstein J.B., Tu D., et al. Quality of life, mucositis, and xerostomia from radiotherapy for head and neck cancers: a report from the NCIC CTG HN2 randomized trial of an antimicrobial lozenge to prevent mucositis. Head Neck 27 (2005) 421-428
19. Goldstein D.P., Hynds Karnell L., Christensen A.J., et al. Health-related quality of life profiles based on survivorship status for head and neck cancer patients. Head Neck 29 (2007) 221-229
20. Rosenthal D.I., Lewin J.S., and Eisbruch A. Prevention and treatment of dysphagia and aspiration after chemoradiation for head and neck cancer. J Clin Oncol 24 (2006) 2636-2643
21. Pow E.H.N., Kwong K.L.W., McMillan A.S., et al. Xerostomia and quality of life after intensity-modulated radiotherapy vs. conventional radiotherapy for early-stage nasopharyngeal carcinoma: initial report on a randomized controlled clinical trial. Int J Radiat Oncol Biol Phys 66 (2006) 981-991
22. Eisbruch A., Schwartz M., Rasch C., et al. Dysphagia and aspiration after chemoradiotherapy for head-and-neck cancer: which anatomic structures are affected and can they be spared by IMRT?. Int J Radiat Oncol Biol Phys 60 (2004) 1425-1439